Stay updated on Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial
Sign up to get notified when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.

Latest updates to the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page
- ChecktodayChange DetectedNo additions or deletions are documented for this page. There is nothing to compare against the current content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s footer/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a minor ClinicalTrials.gov release. No study details (e.g., design, outcomes, eligibility, or dates) appear to have changed.SummaryDifference0.0%

- Check22 days agoChange DetectedRevision: v3.5.2 has been introduced. The previous revision v3.5.0 has been removed.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check58 days agoChange DetectedResults posted for the study (NCT05446740), including dose-level data, study design details, and outcome measures; the page now displays a Results Posted section with related documents.SummaryDifference6%

- Check72 days agoChange DetectedAdded a Publications section with a PubMed-cited article about the study’s vaccine safety and immunogenicity (Hum Vaccin Immunother, 2026;22(1):2631804) and a 'From PubMed' note.SummaryDifference0.2%

Stay in the know with updates to Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Influenza Vaccine Reactogenicity in Younger and Older Adults Clinical Trial page.